How early do we see the CVD benefits of LDL-C lowering?
Prof. Philip Barter presents an analysis of the relationship between treatment duration and CVD benefits of different LDL-c lowering treatments.
Video navigation menu
- Benefits of different statins in relation to treatment duration 00:24
- Comparison of atorvastatin trials versus other statin trials 01:55
- Does it matter how big the reduction in LDL-c or the primary endpoint is? 03:04
- What is the effect of non-statins, ezetimibe and PCSK9 inhibitors? 03:46
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.